Marburg Ion-Beam Therapy Centre MIT

🎗️ In this Breast Cancer Awareness Month, we are thrilled to share groundbreaking research from Shandong First Medical University（Shandong Academy Of Medical Sciences）. Their study highlights the significant role of proton therapy in reducing harmful side effects for breast cancer patients. By precisely targeting radiation, proton therapy minimizes exposure to vital organs like the heart and lungs, reducing long-term complications.   👉 Read “Proton therapy for breast cancer: Reducing toxicity”: https://lnkd.in/gpYg7zGK #BreastCancerResearch #ProtonTherapy #ClinicalTrials #CancerCare 

🎉 Celebrating a Milestone! 🎉 It has been 1 year has passed since the grand opening of the Proton Center of Arkansas! This incredible collaboration between UAMS - University of Arkansas for Medical Sciences, Baptist Health, Arkansas Children’s, and Proton International, LLC has brought groundbreaking proton therapy to children and adults battling cancer in Arkansas. Congratulations to the whole team! #ProtonTherapy #Arkansas #HealthcareInnovation #CancerCare #IBA

Hlavní fyzik Proton Therapy Center Czech s.r.o. Mgr. Vladimír Vondráček spolu s dalšími odborníky zkoumal vyšší biologickou účinnost protonového svazku za použití bóru v oblasti Braggova píku. V rámci výzkumu byly ozařovány specifické buňky karcinomu prostaty nebo glioblastomu protonovým svazkem s přídavkem izotopů 10B nebo 11B ve formě merkaptodekaborátu sodného (BSH) nebo bez něj. Výsledky ukazují, že izotop 11B, oproti izotopu 10B a jiným složkám molekul BSH, zvyšuje usmrcení nádorových buněk protonovými paprsky. Toto pozorované 2 až 3 násobné snížení úrovně přežití za přítomnosti bóru u studovaných buněk karcinomu prostaty nebo glioblastomu naznačuje slibné klinické výsledky pro tyto typy nádorů. Výsledky této studie jsou shrnuty v článku s názvem First independent validation of the proton‑boron capture therapy concept, který vyšel v časopise Scientific reports Sci Rep 14, 19264 (2024). https://lnkd.in/dFqRV7iw

More and more teams explore proton therapy as a safer cancer treatment! #protontherapy https://lnkd.in/eSdhbMn5

🚨 New in ctRO: 👉 Three prospective trials evaluating elective nodal irradiation in the setting of ultrahypofractionated versus moderately hypofractionated and convetionally fractionated prostate radiotherapy were combined and analyzed. 👉 The cumulative incidence of biochemical failure was not significantly different between the cohorts. 👉 Acute grade ≥ 2 GU toxicity was significantly worse in patients treated with ultrahypofractionation, but not acute grade ≥ 3 GU toxicity. 👉 Elective nodal irradiation in the setting of prostate ultrahypofractionation was not associated with worse late toxicities. https://buff.ly/4dDWlRo

Protons are painkillers! Apparently, proton therapy and pain management are closely linked, particularly in treating cancer and other conditions where radiation targets tumors causing discomfort or pain. This is made possible through several key mechanisms: - Targeted nature of protons: By reducing collateral damage, proton therapy minimizes the pain often caused by traditional radiation therapies. - Reducing inflammation-related pain: Proton therapy’s precision spares healthy tissues, leading to less inflammation and fewer painful side effects. - Less damage to nerve endings: The ability to focus radiation on the tumor means that critical structures like nerves are protected, which results in less long-term pain. Clinical evidence is highly supportive: - A study in The Lancet Oncology (2019), authored by T. Makoto et al., found that proton therapy provided significant pain relief for patients with bone metastases, reducing the need for opioids and improving overall quality of life. - Another study published in JAMA Oncology (2016) by R. Frank et al. reported that in patients with head and neck cancers, proton therapy reduced acute and long-term pain by limiting side effects like radiation burns, improving pain control during recovery. - Research published in Frontiers in Oncology (2021) by H. Zhang et al. reviewed proton therapy’s role in palliative care settings, showing that it helped reduce pain in patients with advanced cancers by shrinking tumors without adding toxicity. Proton therapy is also being explored for its potential in non-oncological conditions that cause pain. With the precision of protons, even conditions like trigeminal neuralgia and benign tumors (like acoustic neuromas) are being treated, offering pain relief without invasive surgery. As proton therapy advances—especially with the further precision we at P-Cure are leading—it offers an effective method for pain management, especially in cases of cancer-related pain. By minimizing side effects and reducing the need for surgeries, it enhances patient comfort and quality of life. It’s exciting to see the growing body of research showing its potential in both cancer care and beyond. #ProtonTherapy #PainManagement #CancerCare #PCure #PrecisionMedicine American Society for Radiation Oncology (ASTRO) AAPM Student and Trainees Subcommittee American Society of Clinical Oncology (ASCO) The National Association for Proton Therapy PTCOG-NA Hadassah Medical Center Aron Popovtzer Philip Blumenfeld Jon Feldman Marcel Fang Yair Hillman P-Cure Ltd Philips Elekta Varian Siemens Healthineers PTCOG-NA The National Association for Proton Therapy

Nice example! Congrats to our colleagues! #particletherapy #radonc #radonc

⚙️Welcome to our Rotary International friends from Aix-en-Provence at Marburg Ion-Beam Therapy Centre MIT and UKGM MARBURG this week! 👩🔬During their visit, they had the opportunity to experience a patient’s journey in our department. 🏥It was an exchange of ideas and a great opportunity to strengthen international ties. #friends #Healthcare #innovation With Gisela Falk, Harald Renz, Philipps-Universität Marburg, Radiation Oncology Marburg